Association of single nucleotide polymorphisms in the promoter region of MMP-2 gene with susceptibility to esophageal squamous cell carcinoma in high prevalence area

Tumor

Volumn 29, Issue 4, 2009, Pages 354-357

  Sun, Dong Lan ^a   Duan, Ya Nan ^a   Zhang, Xiao Juan ^a   Wang, Na ^a   Zhou, Rong Miao ^a   Chen, Zhi Feng ^a   Li, Yan ^a  

^a Hebei Cancer Institute   (China)

Author keywords

Disease susceptibility; Esophageal neoplasms; Matrix metalloproteinases; Polymorphism; Single nucleotide

Indexed keywords

GELATINASE A;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FAMILY HISTORY; FEMALE; GASTROINTESTINAL DISEASE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

EID: 77953415074     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2009.04.013     Document Type: Article

References (13)

1. PRICE S J, GREAVES D R, WATKINS H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation [J]. J Biol Chem, 2001, 276(10):7549-7558.
2. ZHOU Y, YU C, MIAO X, et al. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility[J]. Carcinogenesis, 2005, 26(6):1117-1121
3. MILLER S A, DYBES D D, POLESKY H F. A simple salting out procedure for extracting DNA from human nucleated cells[J]. Nucleic Acid Res, 1988, 16(3):1215.
4. HOLLA L I, FASSMANN A, VASKU A, et al. Genetic variations in the human gelatinase a (matrix metalloproteinase-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis[J], J Periodontol, 2005, 76(7):15-19.
5. QIN H, SUN Y, BENVENISTE E N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metallo-proteinase-2 gene expression in astroglioma cells [J]. J Biol Chem, 1999, 274(41):29130-29137.
6. BALTAZAR-RODRIGUEZ L M, ANAYA-VENTURA A, ANDRADE-SOTO M, et al. Polymorphism in the matrix metalloproteinase-2 gene promoter is associated with cervical neoplasm risk in Mexican women [J]. Biochem Genet, 2008,46(3/4);137-144.
7. DELGADO-ENCISO I, CEPEDA-LOPEZ F R, MONRROY-GUIZAR E A, et al. Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population[J]. Gynecol Obstet Invest, 2008,65(1):68-72.
8. YU C, ZHOU Y, MIAO X, et al. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer[J]. Cancer Res, 2004, 64(20):7622-7628.
9. MIAO X, YU C, TAN W, et al. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma[J]. Cancer Res, 2003, 63(14):3987-3990.
10. GRIEU F, LI W Q, IACOPETTA B. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype[J]. Breast Cancer Res Treat, 2004, 88(3):197-204.
11. ROLLIN J, REGINA S, VOURCH P, et al. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer [J]. Lung Cancer, 2007, 56(2):273-280.
12. KADER A K, SHAO L N,DINNEY C P, et al. Matrix metalloproteinase polymorphisms and bladder cancer risk[J]. Cancer Res, 2006, 66(24): 11644-11648.
13. Chinese source.